9cbm

Publication Abstract from PubMed

Agonists targeting alpha(2)-adrenergic receptors (ARs) are used to treat diverse conditions, including hypertension, attention-deficit/hyperactivity disorder, pain, panic disorders, opioid and alcohol withdrawal symptoms, and cigarette cravings. These receptors transduce signals through heterotrimeric Gi proteins. Here, we elucidated cryo-EM structures that depict alpha(2A)-AR in complex with Gi proteins, along with the endogenous agonist epinephrine or the synthetic agonist dexmedetomidine. Molecular dynamics simulations and functional studies reinforce the results of the structural revelations. Our investigation revealed that epinephrine exhibits different conformations when engaging with alpha-ARs and beta-ARs. Furthermore, alpha(2A)-AR and beta(1)-AR (primarily coupled to Gs, with secondary associations to Gi) were compared and found to exhibit different interactions with Gi proteins. Notably, the stability of the epinephrine-alpha(2A)-AR-Gi complex is greater than that of the dexmedetomidine-alpha(2A)-AR-Gi complex. These findings substantiate and improve our knowledge on the intricate signaling mechanisms orchestrated by ARs and concurrently shed light on the regulation of alpha-ARs and beta-ARs by epinephrine.

Distinct binding conformations of epinephrine with alpha- and beta-adrenergic receptors.,Lou JS, Su M, Wang J, Do HN, Miao Y, Huang XY Exp Mol Med. 2024 Sep 2. doi: 10.1038/s12276-024-01296-x. PMID:39218975^[2]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.